Interpace Biosciences, Inc.

OTCPK:IDXG Stok Raporu

Piyasa değeri: US$10.8m

Interpace Biosciences Yönetim

Yönetim kriter kontrolleri 4/4

Interpace Biosciences' CEO is Tom Burnell, appointed in Dec 2020, has a tenure of 3.92 years. total yearly compensation is $678.41K, comprised of 64.2% salary and 35.8% bonuses, including company stock and options. directly owns 1.86% of the company’s shares, worth $200.26K. The average tenure of the management team and the board of directors is 2.8 years and 4.8 years respectively.

Anahtar bilgiler

Tom Burnell

İcra Kurulu Başkanı

US$678.4k

Toplam tazminat

CEO maaş yüzdesi64.2%
CEO görev süresi3.9yrs
CEO sahipliği1.9%
Yönetim ortalama görev süresi2.8yrs
Yönetim Kurulu ortalama görev süresi4.8yrs

Son yönetim güncellemeleri

Recent updates

Interspace Biosciences trades high, appoints new finance chief

Feb 04

Interpace signs licensing agreement for monoclonal antibody platform Das-1

Feb 01

CEO Tazminat Analizi

Tom Burnell'un ücretlendirmesi Interpace Biosciences'un kazancına kıyasla nasıl değişti?
TarihToplam TazminatMaaşŞirket Kazançları
Jun 30 2024n/an/a

US$3m

Mar 31 2024n/an/a

US$1m

Dec 31 2023US$678kUS$436k

US$1m

Sep 30 2023n/an/a

-US$1m

Jun 30 2023n/an/a

-US$2m

Mar 31 2023n/an/a

-US$4m

Dec 31 2022US$634kUS$434k

-US$6m

Sep 30 2022n/an/a

-US$6m

Jun 30 2022n/an/a

-US$6m

Mar 31 2022n/an/a

-US$4m

Dec 31 2021US$588kUS$425k

-US$7m

Sep 30 2021n/an/a

-US$13m

Jun 30 2021n/an/a

-US$18m

Mar 31 2021n/an/a

-US$24m

Dec 31 2020US$935kUS$35k

-US$29m

Tazminat ve Piyasa: Tom's total compensation ($USD678.41K) is about average for companies of similar size in the US market ($USD655.02K).

Tazminat ve Kazançlar: Tom's compensation has been consistent with company performance over the past year.

CEO

Tom Burnell (62 yo)

3.9yrs

Görev süresi

US$678,407

Tazminat

Dr. Thomas W. Burnell, also known as Tom, Ph.D. serves as the President, Chief Executive Officer and Director at Interpace Biosciences, Inc. since December 01, 2020 and serves as its Chairman from February...

Liderlik Ekibi

İsimPozisyonGörev süresiTazminatSahiplik
Thomas Burnell
President3.9yrsUS$678.41k1.86%
$ 200.3k
Christopher McCarthy
Chief Financial Officer1.6yrsUS$332.04k1.04%
$ 111.9k
Sydney Finkelstein
Chief Scientific Officerno dataVeri yokVeri yok
Jody Campbell
Chief Revenue Officer2.8yrsVeri yokVeri yok
Nicole Massoll
Chief Medical Officerless than a yearVeri yokVeri yok
Patrick Kane
VP & Corporate Controller15.4yrsVeri yokVeri yok

2.8yrs

Ortalama Görev Süresi

Deneyimli Yönetim: IDXG's management team is considered experienced (2.8 years average tenure).

Yönetim Kurulu Üyeleri

İsimPozisyonGörev süresiTazminatSahiplik
Thomas Burnell
President3.9yrsUS$678.41k1.86%
$ 200.3k
Joseph Keegan
Independent Director8.8yrsUS$50.00k0.040%
$ 4.3k
Stephen Sullivan
Independent Director20.2yrsUS$62.50k0.056%
$ 6.0k
Vijay Aggarwal
Independent Director2.8yrsUS$50.00k0%
$ 0
Fortunato Rocca
Independent Director4.8yrsUS$40.00k0%
$ 0

4.8yrs

Ortalama Görev Süresi

70yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: IDXG's board of directors are considered experienced (4.8 years average tenure).